Observations placeholder

Sufentanil (R30730, brand name Sufenta) is a synthetic opioid analgesic drug approximately five to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Sufentanil is marketed for use by specialist centers under different trade names, such as Sufenta and Sufentil (India,). Sufentanil with and without lidocaine or mepivacaine is available as a transdermal patch similar to Duragesic in Europe under trade names such as Chronogesic.

Side effects

It is essential for the administering medical professional to be trained in airway management with readily available airway equipment because the drug causes significant respiratory depression and may cause respiratory arrest if given too rapidly or in too high a dose. Other opioid side effects such as heart rhythm irregularity, blood pressure changes and nausea/vomiting can also be present in patients given this drug and should be dealt with accordingly.

Sufentanil has been associated with extremely rare instances of life-threatening anaphylaxis.

On Jan, 30, 2016: 1,239 people reported to have side effects when taking Sufentanil citrate. Among them, 2 people (0.16%) have Hallucination.

Time on Sufentanil citrate when people have Hallucination  :

Gender of people who have Hallucination when taking Sufentanil citrate  :

On Feb, 8, 2016: 1,239 people reported to have side effects when taking Sufentanil citrate. Among them, 58 people (4.68%) have Death.

Time on Sufentanil citrate when people have Death  :

On Feb, 8, 2016: 469 people reported to have side effects when taking Sufenta preservative free. Among them, 29 people (6.18%) have Death.

Time on Sufenta preservative free when people have Death  :